Clinical Trial Update: Lapatinib and WBRT for Patients With Brain Metastases From Lung or Breast Tumors [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the combination of lapatinib with whole-brain radiotherapy for patients with brain metastases from lung or breast tumors has complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases
• Breast Cancer
• Lung Cancer

Drugs mentioned

• Lapatinib (Lapatinib)

Snippet

Sponsor: Hellenic Cooperative Oncology Group | Conditions: Brain Metastases, Lung Tumors | Phase 2 | Status: COMPLETED